Factor V Arg306 → Thr (factor V Cambridge) and factor V Arg306 → Gly mutations in venous thrombotic disease

British Journal of Haematology

Volumn 103, Issue 3, 1998, Pages 888-890

  Franco, R F ^a,b   Maffei, F H ^c   Lourenco, D ^d   Morelli, V ^d   Thomazini, I A ^c   Piccinato, C E ^a   Tavella, M H ^a   Zago, M A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDHERP   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Factor V Arg306 Gly; Factor V Arg306 Thr; Risk factor; Thrombophilia; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; DNA SEQUENCE; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; VEIN THROMBOSIS; GENETIC PREDISPOSITION; GENETICS; INFANT; MIDDLE AGED; MUTATION; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0031593697     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01051.x     Document Type: Article

References (8)

1. Bertina, R.M., Koeleman, P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., van der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64 67.
2. Chan, W.P., Lee, C.K., Kwong, Y.L., Lam, C.K. & Liang, R. (1998) A novel mutation of Arg 306 of factor V gene in Hong Kong Chinese. Blood, 91, 1135-1139.
3. Dählback, B. (1997) Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management. Seminars in Hematology, 34, 217-234.
4. Dählback, B., Carlsson, M. & Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 1004-1008.
5. Poort, S.W. Rosendaal, F.R., Reitsma, P.H. & Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698-3703.
6. Sanger, F., Nicklen, S. & Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 74, 5463-5467.
7. Seligsohn, U. & Zivelin, A. (1997) Thrombophilia as a multigenic disorder. Thrombosis and Haemostasis, 78, 297-301.
8. 306 →Thr) associated with resistance to activated protein C. Blood, 91, 1140-1144.